Skip to main content

Table 2 Comparison of laboratory characteristics of Kawasaki disease according to sonographic findings of gallbladder

From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children

Variables

Non AAC group

AAC group†

Pvalue

(n = 43)

(n = 24)

WBC (/mm3)

13,590 (5,680 ~ 30,300)

13,930 (4,000 ~ 23,620)

0.870

Neutrophils (%)

78.6 (29.3 ~ 95.2)

84.3 (37.5 ~ 95.3)

0.392

Hemoglobin (g/dL)

11.6 (8.7 ~ 14.2)

11.8 (10.0 ~ 14.8)

0.985

Platelet count (/mm3)

354,000 (175,000 ~ 573,000)

274,000 (64,000 ~ 492,000)

0.007*

Albumin (g/dL)

3.9 (2.7 ~ 4.6)

3.4 (2.6 ~ 4.3)

0.001*

Total bilirubin (mg/dL)

1.1 (0.2 ~ 5.7)

2.6 (0.2 ~ 5.4)

0.172

Direct bilirubin (mg/dL)

2.1 (0.1 ~ 5.3)

2.4 (1.6 ~ 4.1)

0.704

AST (IU/L)

84 (19 ~ 1,287)

109 (27 ~ 1,003)

0.729

ALT (IU/L)

159 (6 ~ 898)

167 (25 ~ 1,076)

0.870

γGT (IU/L)

219 (23 ~ 577)

189 (20 ~ 450)

1.000

ESR (mm/h)

44.5 (6 ~ 120)

38 (3 ~ 114)

1.000

CRP (mg/dL)

8.0 (0.6 ~ 26.0)

9.4 (0.2 ~ 26.0)

0.392

PT INR

1.2 (1.0 ~ 1.5)

1.2 (1.0 ~ 10.9)

0.460

aPTT (sec)

43.6 (33.2 ~ 58.7)

45.9 (26.8 ~ 57.7)

0.440

  1. Data are presented as median (range).
  2. *p < 0.05.
  3. †AAC group: the sum of definite AAC and suspected AAC.
  4. AAC, acute acalculous cholecystitis; aPTT, activated partial thromboplastin time; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; γGT, gamma glutamyl transferase, INR, international normalized ratio; PT, prothrombin time; WBC, white blood cell.